Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
To preprint or not to preprint: A debate at the ISMPP

To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting

The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...
Strategic publication planning: A handy infographic for medical affairs

Strategic Publication Planning: Infographic for Medical Affairs

Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Pexels Alexander Suhorucov

Plain Language Summary Development in Japan: Current State and Challenges

This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
EU MedTech Summit 2020

EU MedTech Summit 2020: Highlights and Top 3 Takeaways

How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...
Trends in publication review of articles

Review Article Publication Trends

This poster was presented by representatives from Cactus Life Sciences at the 11th Annual Meeting...

Learn more ABOUT our company.